Advancing R&D with a scientific mindset and academic/business sense

webinar

Fri, 21 Sep 2018, 16:00 CEST (Berlin)

Dr. Guillermo Morales, PhD, MBA, CEO of Innoventyx

Advancing R&D with a scientific mindset and academic/business sense

How do you start a research program and advance it with the limited funds you have? This is a common problem we all face whether you are in industry or in academia. In drug discovery if you don’t have a way to know what compounds you should buy/make then your chances of success are the same as buying a lottery ticket. And even if you have a promising hit/lead compound, how will you improve it? How much should you improve it? And to what end? A publication, patent filing, grant application? In this webinar Dr. Morales will cover these points, foundations to tackle obstacles and make decisions to start and advance research projects.

Current news

Freedom Space by Chemspace March 2026 Update - Now a MASSIVE 296 Billion!
March 5, 2026 10:09 CET
The March 2026 update of Freedom Space brings a significant expansion, now featuring over 296 billion accessible, drug-like products. Created by Chemspace, this collection was built from 39 reaction protocols and 215,000 reagents sourced from 15 of the most reliable suppliers. By prioritizing price and lead time, this version enhances...
Read on
category
Events
Tool of the Month - SpaceMACS
February 26, 2026 14:08 CET
Spotlight on SpaceMACS: Precision Substructure Mining at Scale In the search for the next lead candidate, medicinal chemists often focus on specific structural motifs while requiring absolute synthetic accessibility. This month, we focus on SpaceMACS, our specialized algorithm designed to perform rapid substructure searches across trillions of compounds within massive...
Read on
Introducing SAVI Space - Taking the Step After Enumeration with the SAVI Space
February 25, 2026 11:28 CET
The SAVI Space (short for Synthetically Accessible Virtual Inventory) is a combinatorial Chemical Space designed for ultra-large scale virtual screening. Developed by the U.S. National Institutes of Health (NIH) and transformed by researchers at the University of Hamburg (ZBH), it marks a technical shift from static molecular libraries to dynamic,...
Read on